The HSP90 Inhibitor, AT13387, Is Effective against Imatinib-Sensitive and -Resistant Gastrointestinal Stromal Tumor ModelsTomoko Smyth, Nicola G. Wallis, Thomas Van Looy et al.|Molecular Cancer Therapeutics|2012Cited by 59
Mechanisms of sunitinib malate (SU) resistance in gastrointestinal stromal tumors (GISTs)Michael C. Heinrich, Jonathan A. Fletcher, Monica M. Bertagnolli et al.|Journal of Clinical Oncology|2007Cited by 19
Abstract B184: HSP90 inhibitor STA-9090 potently suppresses heterogeneous KIT kinase-domain mutations responsible for gastrointestinal stromal tumor progression during imatinib therapyJonathan A. Fletcher, George D. Demetri, Maria Dêbiec‐Rychter et al.|Molecular Cancer Therapeutics|2009Cited by 3
Supplementary Figure Legend from The HSP90 Inhibitor, AT13387, Is Effective against Imatinib-Sensitive and -Resistant Gastrointestinal Stromal Tumor ModelsTomoko Smyth, Nicola G. Wallis, Thomas Van Looy et al.|Unknown|2023Cited by 0
Supplementary Figure 2 from The HSP90 Inhibitor, AT13387, Is Effective against Imatinib-Sensitive and -Resistant Gastrointestinal Stromal Tumor ModelsTomoko Smyth, Nicola G. Wallis, Thomas Van Looy et al.|Unknown|2023Cited by 0